Search News Archives
Follow us on
Conferences | Events
Media Partners

PhoreMost and Plexxikon Collaborate to Identify Novel Drug Targets

publication date: May 17, 2018
 | 
author/source: PhoreMost

PhoreMostPhoreMost, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, announce it has signed a collaborative agreement with Plexxikon Inc., the small molecule structure-guided R&D centre of Daiichi Sankyo.

Under the agreement, PhoreMost will apply its next-generation phenotypic screening platform, SITESEEKER®, towards key cancer-driving cellular pathways. The alliance will draw upon expertise in signal transduction from Dr. Simon Cook at the Babraham Institute (Cambridge, UK). The goal of the collaboration will be to deliver novel drug targets that can serve as starting points for new drug discovery initiatives led by Plexxikon.

“We are delighted to have signed our agreement with PhoreMost. The SITESEEKER approach using small peptides to rapidly and systematically search for drug targets can provide significant value to Plexxikon’s structure-guided drug discovery programs,” said Dr. Gideon Bollag, CEO of Plexxikon.

Dr. Chris Torrance CEO of PhoreMost, said: “We are excited to bring our SITESEEKER technology to this collaboration with Plexxikon and the Cook lab, leading experts in cell signalling pathways. This is an ideal partnership to potentially transform biological insights into the next generation of innovative medicines.”

Dr. Simon Cook from the Babraham Institute, said: “I am thrilled to be working together with both PhoreMost and Plexxikon. This is a great example of partners with complementary skill-sets coming together to identify and validate elusive new drug targets.”




 

Popular this month


 

Lose the Solvent Headache with Cole-Parmer VapLock™ Closed Systems


Tomocube adds 3D Fluorescence Imaging to Holotomography Microscopy for World First


ZEISS Elyra 7 with Lattice SIM IntroducedZEISS Elyra 7 with Lattice SIM Introduced


Restek Now Has Even More of What You Need to Keep Your LC Flowing


Metrohm contributes to global monograph modernization initiative


Fused-Core Selectivity Toolkits for Superficially-Porous Particle Method Development


Introducing Renishaw’s New RA816 Biological Analyser


ID Kit – fast, easy, and accurate detection of heroin and other illicit drugs


Safe Evaporative Sample Preparation of High Potency APIs


Simplifying high content screening with the VIAFLO 96

 

 

Can't find what you are looking for?


Search by company or by product


Company Name:

Product:





Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.

Lab Bulletin is published by newleaf marketing communications ltd
Media Partners